Patents by Inventor Xiangfeng Kong

Xiangfeng Kong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240148091
    Abstract: A wig sheath includes a front end portion and a rear end portion. The front end portion is sleeved at a front end of a user head, the rear end portion is sleeved at a rear end of the user head, a plurality of mesh holes are formed in the front end portion and the rear end portion, and the mesh holes are used for fixing the wig. The rear end portion is provided with a fastener. An edge portion is formed at a lower end of the front end portion, and the edge portion fits with the user hairline. When wearing the wig sheath, the user can sleeve the front end portion of the head and stretch the fastener, and sleeve the rear end portion at the head. An edge portion is aligned with the head hairline of the user by regulating the position of the wig sheath.
    Type: Application
    Filed: January 30, 2023
    Publication date: May 9, 2024
    Inventor: Xiangfeng Kong
  • Publication number: 20240011005
    Abstract: The disclosure provides Cas12f polypeptides, fusion proteins comprising such Cas12f polypeptides, CRISPR-Cas12f systems comprising such Cas12f polypeptides or fusion proteins, and methods of using the same.
    Type: Application
    Filed: June 8, 2023
    Publication date: January 11, 2024
    Inventors: Xiangfeng Kong, Lecong Wang, Xuqiang Kong
  • Patent number: 11649444
    Abstract: The present disclosure provides a Cas12i protein (e.g., non-naturally occurring, engineered) comprising an amino acid sequence having at least about 80% (e.g., at least about any of 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, 99.5%, or 100%) identity to the amino acid sequence as set forth in any one of SEQ ID NOs: 1-10 (preferably, SEQ ID NOs: 1-3 and 6, and more preferably, SEQ ID NO: 1).
    Type: Grant
    Filed: August 15, 2022
    Date of Patent: May 16, 2023
    Assignee: HuidaGene Therapeutics Co., Ltd.
    Inventors: Hainan Zhang, Xiangfeng Kong, Qijia Chen
  • Publication number: 20230136278
    Abstract: The present disclosure provides a Cas12i protein (e.g., non-naturally occurring, engineered) comprising an amino acid sequence having at least about 80% (e.g., at least about any of 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, 99.5%, or 100%) identity to the amino acid sequence as set forth in any one of SEQ ID NOs: 1-10 (preferably, SEQ ID NOs: 1-3 and 6, and more preferably, SEQ ID NO: 1).
    Type: Application
    Filed: August 15, 2022
    Publication date: May 4, 2023
    Inventors: Hainan ZHANG, Xiangfeng Kong, Qijia Chen
  • Patent number: D1001425
    Type: Grant
    Filed: November 4, 2022
    Date of Patent: October 17, 2023
    Inventor: Xiangfeng Kong
  • Patent number: D1004256
    Type: Grant
    Filed: November 4, 2022
    Date of Patent: November 14, 2023
    Inventor: Xiangfeng Kong